-transparent.png){kind=logo}
Drug-induced haemolytic anaemia is a commonly encountered clinical situation. Methyldopa-induced haemolytic anaemia, once the most common cause of drug induced haemolysis, is now rarely seen due to decline in its use. We report a case of methyldopa induced immune haemolytic anaemia in a young woman where the diagnosis was initially missed. The major mechanisms of drug induced immune haemolysis and unique characteristics of methyldopa induced haemolysis are also outlined.
Related Publications
Anish Thomas, and
Bridget R James, and
Stephen L Graziano
July 1966,
Lancet (London, England),
Anish Thomas, and
Bridget R James, and
Stephen L Graziano
July 1967,
The Medical journal of Australia,
Anish Thomas, and
Bridget R James, and
Stephen L Graziano
January 1966,
Lancet (London, England),
Anish Thomas, and
Bridget R James, and
Stephen L Graziano
February 1966,
Lancet (London, England),
Anish Thomas, and
Bridget R James, and
Stephen L Graziano
January 1966,
Lancet (London, England),
Anish Thomas, and
Bridget R James, and
Stephen L Graziano
February 1966,
Lancet (London, England),
Anish Thomas, and
Bridget R James, and
Stephen L Graziano
June 1966,
Lancet (London, England),
Anish Thomas, and
Bridget R James, and
Stephen L Graziano
May 1966,
Lancet (London, England),
Anish Thomas, and
Bridget R James, and
Stephen L Graziano
June 1976,
British medical journal,
Anish Thomas, and
Bridget R James, and
Stephen L Graziano
February 1973,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
